The EPS projection of Mellanox Technologies, Ltd. (NASDAQ:MLNX) for quarter ended 2016-09-30 is $0.66. Last week, the projection for EPS was $0.66 against target of $0.66, a month earlier. While 2-months ago, this projection was $0.66 versus forecast of $0.66a quarter months earlier, posting a deviation of 0%.
Mellanox Technologies, Ltd. (NASDAQ:MLNX) posted that 18 days earlier, the share price was revised 3 times on upside. In addition, negative revisions were 0.
In last week, negative EPS revisions were 0 times and positive EPS revisions were 0 times. In last one-month and two month the positive revisions were 0 and 0. While in last 120 and 90 days, positive revisions were 2, and 2, correspondingly.
The per-share earnings downgrade for Mellanox Technologies, Ltd. (NASDAQ:MLNX) in the preceding 30 and 120 were 0 and 2. While in 60 and 90 days were 0, and 2, in that order.
Mellanox Technologies, Ltd. (NASDAQ:MLNX) EPS target was $0.66 for the quarter closed 1. It was based on 4 calls. As on 2016-04-20 the EPS was $0.42. The change was $-0.04, posting a deviation of -8.7%. The price projections gave a standard deviation of 0.01.
Quarterly Sales Estimates
Mellanox Technologies, Ltd. (NASDAQ:MLNX) sales prediction for the fiscal 2017 stands at $260.333 and the median estimate is at $260. Almost 3 analysts gave sales target.
Among this, the highest sales estimate is $268 while the lowest target is $253 showing standard deviation of 7.505%.
As many as 3 analysts have positive sales targets revision while 3 reduced sales estimates, posting a deviation of 0%.
Last month, 3 experts have positive sales number revision. Also, 3 research groups lowered the sales projections, posting a deviation of 0%.
A quarter ago, 3 hiked sales target and 3 reduced sales forecast, posting a deviation of -0.737%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...